Clinical Trial Update: Neuroendocrine and Metabolite Substrates in Schizophrenia

View source ↗

Summary

Clinical trial update on neuroendocrine and metabolite substrates in schizophrenia sponsored by Chang Gung Memorial Hospital; current study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Schizophrenia | Status: UNKNOWN